For the Inventor, By the Inventor

Enter assignee name

Richmond, CA, United States of America

Berlex Laboratories, Inc.

USPTO Granted Patents = 100

Trademarks = 1

Forward Citations = 1,929

Loading Chart...

Loading Chart...

99 inventors (with patents filed for the assignee):

Michael M Morrissey (48 out of 73 patents)

Gary Bruce Phillips (30 out of 81 patents)

Howard P Ng (25 out of 76 patents)

4. David D Davey (22 out of 43 patents)

5. Raju Mohan (18 out of 77 patents)

6. Brad Owen Buckman (17 out of 47 patents)

7. Monica J Kochanny (17 out of 27 patents)

8. Shung C Wu (15 out of 29 patents)

9. William J Guilford (13 out of 39 patents)

10. Wei Xu (12 out of 79 patents)

11. Zuchun Zhao (11 out of 39 patents)

12. Damian O Arnaiz (10 out of 23 patents)

13. Bin Ye (9 out of 22 patents)

14. Kenneth Jay Shaw (9 out of 19 patents)

15. James J Devlin (6 out of 39 patents)

Core Competencies:

N-Heterocyclic Derivatives

NOS Inhibitors

Anti-Neoplastic Drugs

Cancer Therapy

Benzamidine Derivatives

Anti-Coagulants

Polyhydroxylated Monocyclic Derivatives

Somatostatin Analogs

Scintigraphic Imaging Agents

Thio Acid Derived Monocyclic Derivatives

Aryl Substituted Pyrimidine Derivatives

Sympathetic Antagonists

100 patents: Sort by Forward Citations

1. 6887865 - N-heterocyclic derivatives as NOS inhibitors (2005-05-03),

2. 6884418 - Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy (2005-04-26),

3. 6864263 - N-heterocyclic derivatives as NOS inhibitors (2005-03-08),

4. 6849739 - N-heterocyclic derivatives as NOS inhibitors (2005-02-01),

5. 6846829 - N-heterocyclic derivatives as NOS inhibitors (2005-01-25),

6. 6841674 - N-heterocyclic derivatives as NOS inhibitors (2005-01-11),

7. 6841673 - N-heterocyclic derivatives as nos inhibitors (2005-01-11),

8. 6686367 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2004-02-03),

9. 6686364 - Benzamidine derivatives and their use as anti-coagulants (2004-02-03),

10. 6559147 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2003-05-06),

11. 6552030 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2003-04-22),

12. 6498185 - Ortho-anthranilamide derivatives as anti-coagulants (2002-12-24),

13. 6495684 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2002-12-17),

14. 6495574 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2002-12-17),

15. 6492376 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2002-12-10),

Berlex Laboratories, Inc. is a pharmaceutical company specializing in the research, development, and production of innovative medicines. Our mission is to improve patient health and well-being by delivering high-quality medications that address unmet medical needs. With a strong focus on scientific excellence and collaboration, we strive to discover breakthrough therapies in various therapeutic areas. Visit our website to learn more about our portfolio, pipeline, and commitment to advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

100 Patents

#4 in Richmond, CA

#855 in California

#3,647 in US

#7,548 in the World

Richmond, CA, United States of America

Berlex Laboratories, Inc.

Forward Citations = 1,929

99 inventors:

Michael M Morrissey (48 out of 73 patents)

Gary Bruce Phillips (30 out of 81 patents)

Howard P Ng (25 out of 76 patents)

4. David D Davey (22 out of 43 patents)

5. Raju Mohan (18 out of 77 patents)

Please report any incorrect information to support@idiyas.com

Loading…